AI-Driven Antimicrobial Peptide Discovery: Mining and Generation.

Area of Science:

• Biomedical Research
• Computational Chemistry
• Drug Discovery

Background:

• Antimicrobial resistance (AMR) is a growing global health crisis, necessitating novel therapeutic strategies beyond traditional antibiotics.
• Antimicrobial peptides (AMPs) show promise due to bacterial selectivity and slower resistance development, but design is complex.
• Vast peptide sequence space and balancing efficacy with low toxicity present significant challenges in AMP development.

Purpose of the Study:

• To explore the application of artificial intelligence (AI) in accelerating antimicrobial peptide (AMP) discovery.
• To detail AI-driven strategies for identifying and designing novel AMPs to combat antimicrobial resistance (AMR).
• To discuss the potential of AI in overcoming challenges in AMP design and development.

Main Methods:

• AMP mining: Utilizing AI to scan biological sequences for potential AMP candidates.
• Discriminative models: Employing AI to predict the activity and toxicity of identified peptides.
• AMP generation: Leveraging generative AI models to create novel peptide sequences with optimized therapeutic properties.

Main Results:

• AI-driven AMP mining successfully identified and experimentally validated promising AMP candidates.
• Generative AI models show potential for designing synthetic peptides with enhanced efficacy and reduced toxicity.
• AI approaches facilitate efficient navigation of the peptide sequence space for drug discovery.

Conclusions:

• The integration of AI with AMP discovery offers a powerful approach to combat AMR.
• AI can expedite the identification and design of novel, effective, and safe antimicrobial peptides.
• Continued AI integration in biomedical research is crucial for developing next-generation antimicrobial therapies.